Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ULGX > SEC Filings for ULGX > Form 8-K on 8-Apr-2013All Recent SEC Filings

Show all filings for UROLOGIX INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for UROLOGIX INC


8-Apr-2013

Other Events


ITEM 8.01 OTHER EVENTS

On April 8, 2013, Urologix, Inc. (the "Company") issued a press release, attached hereto as Exhibit 99.1, reporting that the Company has obtained the necessary regulatory clearances and permits to sell the Prostiva RF Therapy System in the United States under its own quality system and labeling. The Company licenses the Prostiva RF Therapy System from Medtronic, Inc. pursuant to a License Agreement dated September 6, 2011 and the U.S. regulatory transfer was completed pursuant to the terms of a Transition Services and Supply Agreement dated September 6, 2011.

With the U.S. regulatory transfer, the Company is the licensed manufacturer for the Prostiva RF Therapy System and has manufacturing and regulatory responsibility for the product line.

  Add ULGX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ULGX - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.